prostate cancer- sleep study

  • Research type

    Research Study

  • Full title

    The affect of androgen deprivation therapy on sleep disturbance in patients with prostate cancer- A feasibility study (DEPRIVED)

  • IRAS ID

    228507

  • Contact name

    Stephen Mangar

  • Contact email

    Stephen.Mangar@imperial.nhs.uk

  • Sponsor organisation

    Imperial College Healthcare NHS Trust

  • Duration of Study in the UK

    2 years, 0 months, 0 days

  • Research summary

    The quality of sleep can be affected by a diagnosis of cancer and its treatment. Hormonal treatment for prostate cancer can cause fatigue but little is known about its effect on sleep quality, and this may vary according to different treatments administered. Sleep hygiene can directly affect a patient's quality of life, and a better understanding may allow for earlier therapeutic intervention in order to improve cancer survivorship for the patient and also has implications for their sleeping partners. This study aims to discern the effect of not only what a diagnosis of prostate cancer has on sleep quality , but also the effect that hormonal treatment has on sleep hygiene both subjectively by using a validated questionnaire and objectively by using actigraphy,

  • REC name

    London - Stanmore Research Ethics Committee

  • REC reference

    19/LO/0178

  • Date of REC Opinion

    27 Mar 2019

  • REC opinion

    Further Information Favourable Opinion